Zusammenfassung
In der Therapie der Mitralklappeninsuffizienz (MI) hat sich die rekonstruktive Klappenchirurgie zum Goldstandard entwickelt. Diese ist dem prothetischen Klappenersatz hinsichtlich der perioperativen Komplikationsraten und der Langzeitergebnisse deutlich überlegen. Zudem setzt sich zunehmend ein minimal-invasives chirurgisches Vorgehen durch, welches das operative Trauma reduziert und dem konventionellen Eingriff im Ergebnis mindestens ebenbürtig ist. Allerdings bleibt die Operation einer wachsenden Zahl von Patienten verwehrt. Hierbei handelt es sich v. a. um ältere Patienten mit reduzierter Ventrikelfunktion und funktioneller MI, die häufig relevante Komorbiditäten aufweisen. Für diese Patienten können katheterbasierte Mitralklappentherapien eine gute Alternative zum chirurgischen Vorgehen darstellen. Die meisten der neuen interventionellen Techniken befinden sich in experimentellen oder frühen klinischen Entwicklungsstadien. Einzig mit dem MitraClip®-System, welches eine interventionelle Segelplastik ermöglicht, besteht inzwischen umfassende klinische Erfahrung. Für den Erfolg eines patientenorientierten Mitralklappenprogramms ist die Integration chirurgischer und interventioneller Verfahren an einem Herzzentrum maßgeblich. Die Bildung eines interdisziplinären sog. „Heart-Teams“, das sich aus Kardiologen und Herzchirurgen zusammensetzt, ist hierfür von entscheidender Bedeutung.
Abstract
Surgical mitral valve repair has constantly evolved to become the standard of care for severe mitral regurgitation (MR) with superior acute and long-term results compared to valve replacement. Minimally-invasive surgical techniques have been successful in reducing operative trauma while yielding equivalent or even superior results compared to the conventional sternotomy approach. However, due to elevated operative risk a growing proportion of patients are not referred for surgery, especially elderly patients with reduced ventricular function and functional MR who often present with relevant comorbidities. It is for these patients that transcatheter-based therapies may represent an attractive option. While most interventional techniques are still in experimental or early clinical stages of development, relevant clinical experience has been gained with the MitraClip® device. For successful implementation of a patient-centered mitral valve program, integration of surgical and interventional treatment modalities within a heart center is of paramount importance. This is best accomplished by an interdisciplinary dedicated heart team consisting of cardiologists and cardiac surgeons.
Literatur
Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular hear diseases: a population-based study. Lancet 368:1005–1011
Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146
Carpentier A (1983) Cardiac valve surgery – the „Frenche correction“. J Thorac Cardiovasc Surg 86:323–337
David TE, Ivanov J, Armstrong S, Rakowski H (2003) Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg 125:1143–1152
Conradi L, Treede H, Deuse T et al (2010) Minimally-invasive mitral valve surgery: evolution of the technique to the standard of care for mitral repair. J Thorac Cardiovasc Surg 58(Suppl 1):119
Mirabel M, Iung B, Baron G et al (2007) What are the characteristics fo patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28:1358–1365
Gilbert BW, Schatz RA, VonRamm OT et al (1976) Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation. Circulation 54:716–723
Wu AH, Aaronson KD, Bolling SF et al (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45:381–387
Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–e142
Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D et al (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883
Iung B, Gohlke-Bärwolf C, Tornos P et al (2002) Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 23:1253–1266
Kang DH, Kim JH, Rim JH et al (2009) Comparison of early versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119:797–804
Montant P, Chenot F, Robert A et al (2009) Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg 138:1339–1348
Topilsky Y, Suri R, Schaff HV, Enriquez-Sarano M (2010) When to intervene for asymptomatic mitral valve regurgitation. Semin Thoracic Cardiovasc Surg 22:216–224
Lawrie GM (1998) Mitral valve repair vs replacement. Current recommendations and long-term results. Cardiol Clin 16:437–448
Mohty D, Orszulak TA, Schaff HV et al (2001) Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 104:I1-I7
Perier P, Hohenberger W, Lakew F et al (2008) Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the „respect rather than resect“ approach. Ann Thorac Surg 86:718–725
Alfieri O, Maisano F, De Bonis M et al (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 22:674–681
David TE, Armstrong S, Sun Z (1995) Left ventricular function after mitral valve surgery. J Heart Valve Dis 4(Suppl2):175–180
Modi P, Hassan A, Chitwood WR Jr (2008) Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 34:943–952
Mihaljevic T, Cohn LH, Unic D et al (1994) One thousand minimally invasive valve operations: early and late results. Ann Thorac Surg 240:529–534
Reichenspurner H, Detter C, Deuse T et al (2005) Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques. Ann Thorac Surg 79:485–490
Bach DS, Bolling SF (1996) Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 78:966–969
Mihaljevic T, Lam BK, Rajeswaran J et al (2007) Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49:2191–2201
Schofer J, Siminiak T, Haude M et al (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation. Circulation 120:326–333
Chiam PTL, Ruiz CE (2011) Percutaneous transcatheter mitral valve repair: a classification of the technology. J Am Coll Cardiol Intv 4:1–13
Harnek J, Webb JG, Kuck KH et al (2011) Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv 4:115–122
Sack S, Kahlert P, Bilodeau L et al (2009) Percutaneous transvenous mitral annuloplasty: initial human experience. Circ Cardiovasc Interv 2:277–284
Choure AJ, Garcia MJ, Hesse B et al (2006) In vivo analysis of the anatomical relationship of coronary sinus to mitral anulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol 48:1938–1945
Tops LF, Van de Veire NR, Schuijf JD et al (2007) Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation 115:1426–1432
Lansac E, Di Centa I, Al Attar N et al (2008) Percutaneous mitral annuloplasty through the coronary sinus: an anatomic point of view. J Thorac Cardiovasc Surg 135:376–381
Feldman T, Wasserman HS, Herrmann HC et al (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I clinical trial. J Am Coll Cardiol 46:2134–2140
Feldman T, Kar S, Rinaldi M et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol 54:686–694
Feldman T, Foster E, Glower DD et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406
Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381
Rudolph V, Knap M, Franzen O et al (2011) Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol [accepted for publication]
Conradi L, Treede H, Franzen O et al (2011) Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg Apr 14 [Epub ahead of print]
Gummert JF, Funktat AK, Beckmann A et al (2011) Cardiac surgery in Germany during 2010: a report on behalft of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 59:259–267
Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555
Holmes DR Jr, Mack MJ (2011) Transcatheter valve therapy a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 58:445–455
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conradi, L., Treede, H., Baldus, S. et al. Therapie der Mitralklappeninsuffizienz. Herz 36, 677–685 (2011). https://doi.org/10.1007/s00059-011-3531-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-011-3531-7
Schlüsselwörter
- Mitralklappeninsuffizienz
- Mitralklappenrekonstruktion
- Minimal-invasive Operationsverfahren
- MitraClip®
- „Heart-Team“